Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
23andMe Cuts 40% Of Workforce, Discontinues Drug Development
Nov 14 2024
•
By
Marion Webb
23andMe
(Shutterstock)
Explore how consumer health is evolving. On the go.
David Ridley hosts in-depth conversations with industry leaders.
More from Strategy
More from HBW Insight